Literature DB >> 16368552

Optimal design of Ig 5' primers for construction of diverse phage antibody library established to select anti-HAb18GEF and anti-DOTA-Y Fabs for hepatoma pretargeting RIT.

Sihe Zhang1, Jinliang Xing, Qing Zhang, Fei Song, Yu Li, Xiangmin Yang, Zhinan Chen.   

Abstract

Phage antibody library yields antibodies with higher affinity against different antigens, if diverse IgV gene repertoires can be amplified. As the currently available Fab primer sets cannot guarantee efficient amplification with high diversity, and because rare cloning sites can be found in certain Ig genes, here, we present an optimal set of Ig 5' primers, compatible with Fd 5' clone site replaced pComb3 vector, for diverse Fab phage display library construction. These novel Fab primes designed based on the newly classified IgV families, not only have best match and highest coverage for IgV family with minimized N-terminal amino acid changes, but also present good amplification diversity and efficiency of Ig gene from mice immunized with different forms of antigens (HAb18GEF, KLH-DOTA-Y, and HAb18G/pcDNA3). A high quality immune phage library with good diversity was constructed based on the mixed Ig repertoire, and five high affinity Fab antibodies were selected to specifically bind to HAb18GEF, DOTA-Y and an irrelevant antigen gamma-sm, respectively. This novel Fab primers set can be applied to the construction of diverse phage antibody library and the anti-HAb18GEF and anti-DOTA-Y Fab antibodies lay a solid foundation for radioimmunotherapy of hepatoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368552     DOI: 10.2741/1919

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  4 in total

1.  90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.

Authors:  Guozheng Liu; Shuping Dou; Yuxia Liu; Yuzhen Wang; Mary Rusckowski; Donald J Hnatowich
Journal:  Bioconjug Chem       Date:  2011-11-03       Impact factor: 4.774

2.  An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.

Authors:  Guozheng Liu; Shuping Dou; Mary Rusckowski; Donald J Hnatowich
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

3.  Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.

Authors:  Jing Liu; Qing Zhang; Hang Chen; Zhihui Gao; Yao Li; Zhongyuan Sun; Rong Xiang; Sihe Zhang
Journal:  Oncotarget       Date:  2016-06-21

Review 4.  Combination Radioimmunotherapy Strategies for Solid Tumors.

Authors:  Javeria Zaheer; Hyeongi Kim; Yong-Jin Lee; Jin Su Kim; Sang Moo Lim
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.